Literature DB >> 17179479

The response of CD24(-/low)/CD44+ breast cancer-initiating cells to radiation.

Tiffany M Phillips1, William H McBride, Frank Pajonk.   

Abstract

BACKGROUND: If cancer arises and is maintained by a small population of cancer-initiating cells within every tumor, understanding how these cells react to cancer treatment will facilitate improvement of cancer treatment in the future. Cancer-initiating cells can now be prospectively isolated from breast cancer cell lines and tumor samples and propagated as mammospheres in vitro under serum-free conditions.
METHODS: CD24(-/low)/CD44+ cancer-initiating cells were isolated from MCF-7 and MDA-MB-231 breast cancer monolayer cultures and propagated as mammospheres. Their response to radiation was investigated by assaying clonogenic survival and by measuring reactive oxygen species (ROS) levels, phosphorylation of the replacement histone H2AX, CD44 levels, CD24 levels, and Notch-1 activation using flow cytometry. All statistical tests were two-sided.
RESULTS: Cancer-initiating cells were more resistant to radiation than cells grown as monolayer cultures (MCF-7: monolayer cultures, mean surviving fraction at 2 Gy [SF(2Gy)] = 0.2, versus mammospheres, mean SF(2Gy) = 0.46, difference = 0.26, 95% confidence interval [CI] = 0.05 to 0.47; P = .026; MDA-MB-231: monolayer cultures, mean SF(2Gy) = 0.5, versus mammospheres, mean SF(2Gy) = 0.69, difference = 0.19, 95% CI = -0.07 to 0.45; P = .09). Levels of ROS increased in both mammospheres and monolayer cultures after irradiation with a single dose of 10 Gy but were lower in mammospheres than in monolayer cultures (MCF-7 monolayer cultures: 0 Gy, mean = 1.0, versus 10 Gy, mean = 3.32, difference = 2.32, 95% CI = 0.67 to 3.98; P = .026; mammospheres: 0 Gy, mean = 0.58, versus 10 Gy, mean = 1.46, difference = 0.88, 95% CI = 0.20 to 1.56; P = .031); phosphorylation of H2AX increased in irradiated monolayer cultures, but no change was observed in mammospheres. Fractionated doses of irradiation increased activation of Notch-1 (untreated, mean = 10.7, versus treated, mean = 15.1, difference = 4.4, 95% CI = 2.7 to 6.1, P = .002) and the percentage of the cancer stem/initiating cells in the nonadherent cell population of MCF-7 monolayer cultures (untreated, mean = 3.52%, versus treated, mean = 7.5%, difference = 3.98%, 95% CI = 1.67% to 6.25%, P = .009).
CONCLUSIONS: Breast cancer-initiating cells are a relatively radioresistant subpopulation of breast cancer cells and increase in numbers after short courses of fractionated irradiation. These findings offer a possible mechanism for the accelerated repopulation of tumor cells observed during gaps in radiotherapy.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17179479     DOI: 10.1093/jnci/djj495

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  565 in total

Review 1.  The role of epigenetic regulation in stem cell and cancer biology.

Authors:  Lilian E van Vlerken; Elaine M Hurt; Robert E Hollingsworth
Journal:  J Mol Med (Berl)       Date:  2012-06-02       Impact factor: 4.599

Review 2.  Breast cancer stem cell hypothesis: clinical relevance (answering breast cancer clinical features).

Authors:  Nuria Rodríguez Salas; Enrique González González; Carlos Gamallo Amat
Journal:  Clin Transl Oncol       Date:  2010-06       Impact factor: 3.405

3.  CD44 is a biomarker associated with human prostate cancer radiation sensitivity.

Authors:  WeiWei Xiao; Peter H Graham; Carl A Power; Jingli Hao; John H Kearsley; Yong Li
Journal:  Clin Exp Metastasis       Date:  2011-09-28       Impact factor: 5.150

Review 4.  microRNAs and EMT in mammary cells and breast cancer.

Authors:  Josephine A Wright; Jennifer K Richer; Gregory J Goodall
Journal:  J Mammary Gland Biol Neoplasia       Date:  2010-05-25       Impact factor: 2.673

Review 5.  MicroRNAs: new players in the DNA damage response.

Authors:  Hailiang Hu; Richard A Gatti
Journal:  J Mol Cell Biol       Date:  2010-12-23       Impact factor: 6.216

6.  Prognostic value of periostin in early-stage breast cancer treated with conserving surgery and radiotherapy.

Authors:  Changyou Li; Jing Xu; Qi Wang; Shaoqing Geng; Zheng Yan; Jin You; Zhenfeng Li; Xiao Zou
Journal:  Oncol Lett       Date:  2018-03-21       Impact factor: 2.967

Review 7.  Cancer stem cells and radioresistance.

Authors:  Kiera Rycaj; Dean G Tang
Journal:  Int J Radiat Biol       Date:  2014-03-07       Impact factor: 2.694

Review 8.  Circulating tumor cells: from bench to bedside.

Authors:  Marija Balic; Anthony Williams; Henry Lin; Ram Datar; Richard J Cote
Journal:  Annu Rev Med       Date:  2012-10-18       Impact factor: 13.739

9.  HER2-associated radioresistance of breast cancer stem cells isolated from HER2-negative breast cancer cells.

Authors:  Nadire Duru; Ming Fan; Demet Candas; Cheikh Menaa; Hsin-Chen Liu; Danupon Nantajit; Yunfei Wen; Kai Xiao; Angela Eldridge; Brett A Chromy; Shiyong Li; Douglas R Spitz; Kit S Lam; Max S Wicha; Jian Jian Li
Journal:  Clin Cancer Res       Date:  2012-10-22       Impact factor: 12.531

10.  "The development tumor model" to study and monitor the entire progression of both primary and metastatic tumors.

Authors:  Enrico Brognaro
Journal:  Tumour Biol       Date:  2013-11-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.